New Faculty

Dr. Bryan Kraft joins the Department of Medicine

Bryan Kraft, MD

Dr. Bryan D. Kraft is a native of Nashville, Tennessee and received his Bachelor’s degree in Biology at the George Washington University in Washington, District of Columbia, and his Medical Degree from the University of Tennessee College of Medicine in Memphis, Tennessee. He completed an Internal Medicine residency and a Pulmonary, Allergy, and Critical Care Medicine fellowship at Duke University Medical Center in Durham, North Carolina, where he also received advanced training in Undersea and Hyperbaric Medicine at the Duke Center for Hyperbaric Medicine and Environmental Physiology. Dr. Kraft currently serves as Director of Medical Critical Care for Barnes Jewish Hospital and rounds in the Medical Intensive Care Unit (ICU).

Dr. Kraft has a research background and has conducted a variety of clinical and translational studies in sepsis, pneumonia, hyperbaric oxygen therapy, pulmonary alveolar proteinosis, COVID-19, and acute respiratory distress syndrome (ARDS). Specifically, Dr. Kraft has developed nonhuman primate models of pneumococcal pneumonia that have helped to bring therapies to clinical testing, including low-dose inhaled carbon monoxide, a novel potential ARDS therapy, and heparin-based blood purification, a novel potential sepsis therapy. Dr. Kraft also has experience in biomarker and biorepository development, and was the founding principal investigator of the Duke University ICU Biorepository. Dr. Kraft is a self-described life-long learner and has a love of teaching. Over the last 20+ years, he has taught high school students, college students, medical students, graduate students, respiratory therapy students, residents, and fellows in the classroom and clinical settings.

Prior to joining the faculty of Washington University School of Medicine in 2021, Dr. Kraft was on faculty at Duke University from 2013-2021. Key interests include Director of Medical Critical Care and rounding in the Medical Intensive Care Unit (ICU). Dr. Kraft’s research includes conducting a variety of clinical and translational studies in sepsis, pneumonia, hyperbaric oxygen therapy, pulmonary alveolar proteinosis, COVID-19, and acute respiratory distress syndrome (ARDS). He has developed nonhuman primate models of pneumococcal pneumonia that have helped to bring therapies to clinical testing, including low-dose inhaled carbon monoxide, a novel potential ARDS therapy, and heparin-based blood purification, a novel potential sepsis therapy.